Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New combo therapy aims to wake up the brain after stroke

NCT ID NCT07228871

Symptom relief Sponsor: Ankara Etlik City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding a type of brain stimulation (called continuous theta burst stimulation) to mirror therapy can improve hemispatial neglect in people who have had a stroke. Neglect means the brain ignores one side of the world, often the left. Twenty-two stroke survivors will receive either mirror therapy alone or mirror therapy plus brain stimulation for two weeks. Researchers will measure changes in daily life awareness and basic activities.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcranial magnetic stimulation (TMS) and mirror therapy
What this could lead to
If it works, this could offer a new, non-drug way to help stroke survivors regain awareness of their left side, improving daily function.
What could go wrong
This is a very small, early study with only 22 people, so results may not apply to everyone. The treatment is short (2 weeks) and benefits may not last.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 22 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Ischemic/haemorrhagic stroke 2. Right hemisphere lesion 3. Patients with a duration of more than 7 days but less than 1 year from the date of the event 4. Aged between 18 and 75 years 5. Patients with a Mini Mental Test Score ≥ 24 Exclusion Criteria: 1. History of recurrent stroke 2. Presence of vision or hearing problems 3. Use of medication affecting cognitive function 4. History of epilepsy 5. Pregnancy or breastfeeding 6. History of malignancy 7. Pacemaker 8. Presence of metallic implants in the brain or scalp (including cochlear implant) 9. History of premorbid dementia 10. Presence of psychiatric or additional neurological disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemispatial neglect are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

perceptual disorders stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemispatial neglect

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ankara Etlik City Hospital

    RECRUITING

    Ankara, Yenimahalle, 06010, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.